Table 3– Summary of models for detecting severe chronic obstructive pulmonary disease (COPD): validation sample
Prediction variables used in the modelDefinition of groupPopulation %Cases# %Risk
General (unstaged) CART modelling
 Questionnaire data only
  High riskPatient reports doctor-diagnosed COPD/emphysema or dyspnoea ≥grade 3 or BMI <20 kg·m−2 or wheeze with shortness of breath19.670.011.4
  Low riskEveryone else80.430.01.2
 Pre-BD peak flow and questionnaire data
  HighPEF per Ht2 ≤1.8 L·s−1·m−29.093.333.3
  LowPEF per Ht2 >1.8 L·s−1·m−291.06.70.2
 Pre- and post-BD peak flow and questionnaire data
  HighPre-BD PEF per Ht2 ≤1.3 L·s−1·m−2 or post-BD PEF per Ht2 ≤1.8 L·s−1·m−27.592.239.3
  LowPre-BD PEF per Ht2 >1.3 L·s−1·m−2 and post-BD PEF per Ht2 >1.8 L·s−1·m−292.57.80.3
Staged screening models
 Questionnaire data only
  High riskSymptomatic73.897.84.2
  Low riskAsymptomatic26.22.20.3
 Pre-BD peak flow and questionnaire data
  High riskSymptomatic and PEF per Ht2 ≤1.8 L·s−1·m−28.191.136.0
  Low riskAsymptomatic or PEF per Ht2 >1.8 L·s−1·m−291.98.90.3
 Pre- and post-BD peak flow and questionnaire data
  High riskSymptomatic and pre-BD PEF per Ht2 ≤1.8 L·s−1·m−28.191.136.0
  Low riskAsymptomatic or pre-BD PEF per Ht2 >1.8 L·s−1·m−291.98.90.3
  • Data for risk are presented as positive predictive value. CART: classification and regression tree; BD: bronchodilator; BMI: body mass index; PEF: peak expiratory flow; Ht: height. #: sensitivity.